Publications by authors named "Ignac Ovari"

Claim this Profile
T
The interaction of AB-680, a CD73 inhibitor, with NBTI, a nucleoside transporter inhibitor, on the adenosinergic control of atrial contractility.
Ignac Ovari, Agnes Boglarka Brezniczky, Attila Laczovics, Ervin Berényi, Tamas Erdei

Front Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The flexibility of SABRE, a new quantitative receptor function model, when fitting challenging concentration-effect data.
Barbara Olah, Vera Tarjanyi, Barbara Takacs, Edua Pluzsnyik, Gabor Viczjan, Ignac Ovari

Front Pharmacol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ex vivo effects of hypoxanthine-tricyclano, a synthetic adenosine analogue, on rat left and right atria.
Ignac Ovari, Gabor Viczjan, Miklos Bege, Aniko Borbas, Pal Herczegh

Gen Physiol Biophys· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of the way of regression on the results obtained by the receptorial responsiveness method (RRM), a procedure to estimate a change in the concentration of a pharmacological agonist near the receptor.
Ignac Ovari, Gabor Viczjan, Tamas Erdei, Barbara Takacs, Vera Tarjanyi

Front Pharmacol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of a long-term treatment with cannabidiol-rich hemp extract oil on the adenosinergic system of the zucker diabetic fatty (ZDF) rat atrium.
Gabor Viczjan, Anna Szilagyi, Barbara Takacs, Ignac Ovari, Reka Szekeres

Front Pharmacol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolated Hallucination as a Consequence of SARS-CoV-2 Infection in a 10-year-old Child.
Apollónia Pleszkó, Annamária Pauleczki, Ignác Óvári, József Óvári, Péter Hauser

Clin Child Psychol Psychiatry· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Body of Circumstantial Evidence for the Irreversible Ectonucleotidase Inhibitory Action of FSCPX, an Agent Known as a Selective Irreversible A Adenosine Receptor Antagonist So Far.
Gabor Viczjan, Tamas Erdei, Ignac Ovari, Nora Lampe, Reka Szekeres

Int J Mol Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis